• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Organ transplant tech developer Paragonix opens new U.S. HQ

Organ transplant tech developer Paragonix opens new U.S. HQ

October 4, 2023 By Sean Whooley

Paragonix Technologies Updated LogoParagonix Technologies announced today that it opened its new corporate headquarters in Waltham, Massachusetts.

The organ transplant tech company says its expansion reflects continued growth and its commitment to serving clinicians and patients worldwide. Paragonix’s facility features state-of-the-art R&D laboratories and collaborative spaces. It aims to foster innovation and teamwork across departments in the evolving field of organ transplantation.

According to a news release, the 34,000-square-foot center serves as a consolidated hub of Paragonix’s diverse operations. The company highlighted its location in what it called “the vibrant technology corridor” of Greater Boston. Moving headquarters comes during a phase of accelerated growth for Paragonix, too.

The company said it designed the facility’s capacity to meet escalating customer demand and accommodate future expansion. Paragonix also plans to continue to grow its own team in the meantime. Dr. Lisa Anderson, Paragonix CEO and co-founder, called the company’s evolution “remarkable.”

“Today, we are thrilled to inaugurate our first major U.S. headquarters, a significant step forward in continuing our pioneering research and development efforts in transplant products and services,” Anderson said. “The facility will act as a hub for all contributors to our mission, enabling us to redefine standards of care and offer unparalleled support to the organ transplant community.”

Paragonix’s expansion follows FDA clearance of its BAROguard donor lung preservation system in August. That marked the fourth FDA clearance for the company. It plans for the new headquarters to accommodate support teams as it grows its pipeline of next-generation devices, too.

“The new headquarters will enable us to cater efficiently to the growing needs of our business and escalating demands of our clients,” said Garrett Riddle, SVP of operations at Paragonix. “We are proud to facilitate this essential expansion, allowing Paragonix to develop innovative transplant solutions in a unified, dynamic environment.”

Filed Under: Business/Financial News, News Well, Transplants Tagged With: Paragonix Technologies

More recent news

  • Carlsmed names chief product and AI officer as it claims CMS reimbursements
  • Integra LifeSciences says Cincinnati plant flooding will cost millions
  • Mendaera rolls out handheld needle robot paired with Butterfly ultrasound probe
  • Edwards earns FDA approval for first-of-its-kind size-adjustable pediatric heart valve
  • Leading medical device experts and MDO launch Medtech Innovation Board

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy